INTRODUCTION AND HYPOTHESIS: A paucity of data exists addressing the quality of care provided to women with pelvic organ prolapse (POP). We sought to develop a means of measuring this quality through the development of quality-of-care indicators (QIs). METHODS: QIs were modeled after those previously described in the Assessing the Care of Vulnerable Elders (ACOVE) project. The indicators were then presented to a panel of nine experts. Using the RAND Appropriateness Method, we analyzed each indicator's preliminary rankings. A forum was then held in which each indicator was thoroughly discussed by the panelists as a group, after which panelists individually re-rated the indicators. QIs with median scores of at least 7 were considered valid. RESULTS: QIs were developed that addressed screening, diagnosis, work-up, and both nonsurgical and surgical management. Areas of controversy included whether screening should be performed to identify prolapse, whether pessary users should undergo a vaginal examination by a health professional every 6 months versus annually, and whether a colpocleisis should be offered to older women planning to undergo surgery for POP. Fourteen out of 21 potential indicators were rated as valid for pelvic organ prolapse (median score ≥7). CONCLUSION: We developed and rated 14 potential quality indicators for the care of women with POP. Once these QIs are tested for feasibility they can be used on a larger scale to measure and compare the care provided to women with prolapse in different clinical settings.
INTRODUCTION AND HYPOTHESIS: A paucity of data exists addressing the quality of care provided to women with pelvic organ prolapse (POP). We sought to develop a means of measuring this quality through the development of quality-of-care indicators (QIs). METHODS: QIs were modeled after those previously described in the Assessing the Care of Vulnerable Elders (ACOVE) project. The indicators were then presented to a panel of nine experts. Using the RAND Appropriateness Method, we analyzed each indicator's preliminary rankings. A forum was then held in which each indicator was thoroughly discussed by the panelists as a group, after which panelists individually re-rated the indicators. QIs with median scores of at least 7 were considered valid. RESULTS: QIs were developed that addressed screening, diagnosis, work-up, and both nonsurgical and surgical management. Areas of controversy included whether screening should be performed to identify prolapse, whether pessary users should undergo a vaginal examination by a health professional every 6 months versus annually, and whether a colpocleisis should be offered to older women planning to undergo surgery for POP. Fourteen out of 21 potential indicators were rated as valid for pelvic organ prolapse (median score ≥7). CONCLUSION: We developed and rated 14 potential quality indicators for the care of women with POP. Once these QIs are tested for feasibility they can be used on a larger scale to measure and compare the care provided to women with prolapse in different clinical settings.
Authors: Elizabeth A McGlynn; Steven M Asch; John Adams; Joan Keesey; Jennifer Hicks; Alison DeCristofaro; Eve A Kerr Journal: N Engl J Med Date: 2003-06-26 Impact factor: 91.245
Authors: Kristin Rooney; Kimberly Kenton; Elizabeth R Mueller; Mary Pat FitzGerald; Linda Brubaker Journal: Am J Obstet Gynecol Date: 2006-12 Impact factor: 8.661
Authors: Nallini Gnanadesigan; Debra Saliba; Carol P Roth; David H Solomon; John T Chang; John Schnelle; Rick Smith; Paul G Shekelle; Neil S Wenger Journal: J Am Med Dir Assoc Date: 2004 May-Jun Impact factor: 4.669
Authors: Ingrid E Nygaard; Rebecca McCreery; Linda Brubaker; AnnaMarie Connolly; Geoff Cundiff; Anne M Weber; Halina Zyczynski Journal: Obstet Gynecol Date: 2004-10 Impact factor: 7.661
Authors: Jennifer T Anger; Victoria C S Scott; Krista Kiyosaki; Aqsa A Khan; Avivah Weinberg; Sarah E Connor; Carol P Roth; Neil Wenger; Paul Shekelle; Mark S Litwin Journal: Neurourol Urodyn Date: 2013-09-16 Impact factor: 2.696
Authors: Pamela S Fairchild; Neil S Kamdar; Emily R Rosen; Carolyn W Swenson; Dee E Fenner; John O DeLancey; Daniel M Morgan Journal: Int Urogynecol J Date: 2016-11-17 Impact factor: 2.894
Authors: Alexandriah N Alas; Catherine Bresee; Karyn Eilber; Karen Toubi; Rezoana Rashid; Carol Roth; Paul Shekelle; Neil Wenger; Jennifer T Anger Journal: Am J Obstet Gynecol Date: 2014-10-31 Impact factor: 8.661